Search

Displaying results 5311 - 5320 of 8698 in total

Drug
Eucalyptus globulus leaf
go.drugbank.com/drugs/DB14320
Approved
It is not an approved drug.
Drug
Heterotheca inuloides flower
go.drugbank.com/drugs/DB14331
Approved
It is not an approved drug.
Drug
Nelumbo nucifera flower
go.drugbank.com/drugs/DB14333
Approved
It is not an approved drug.
Drug
Arnica montana flower
go.drugbank.com/drugs/DB14343
Approved
It is not an approved drug.
Drug
Equisetum arvense top
go.drugbank.com/drugs/DB14349
ApprovedWithdrawn
It is not an approved drug.
Drug
Salix alba bark
go.drugbank.com/drugs/DB14274
Approved
It is not an approved drug.
Target
V-type immunoglobulin domain-containing suppressor of T-cell activation
go.drugbank.com/bio_entities/BE0010797
TargetHumans
Immunoregulatory receptor which inhibits the T-cell response (PubMed:24691993). May promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling (By similarity). … May stimulate MMP14-mediated MMP2 activation (PubMed:20666777)
Synonyms: Platelet receptor Gi24, V-set immunoregulatory receptor
Drug
Girentuximab
go.drugbank.com/drugs/DB05304
Investigational
Girentuximab is a monoclonal chimeric (mouse/human) antibody directed against carbonic anhydrase IX, an antigen expressed in 95% of clear cell renal cell carcinomas (RCC).
Drug
AP1081
go.drugbank.com/drugs/DB05233
Experimental
A transdermal gel containing ethinyl estradiol and norelgestromin being investigated by Antares Pharma for use as a female contraceptive.
Drug
Seproxetine
go.drugbank.com/drugs/DB06731
Experimental
It is an active metabolite of fluoxetine. Seproxetine was being investigated by Eli Lilly as an antidepressant but development was never completed and the drug was never marketed.
Categories: Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C9 Inhibitors